Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.69 |
| ▸ | LMNA | P02545 | 4/20 | 0.56 |
| ▸ | TSHR | P16473 | 2/20 | 0.50 |
| ▸ | LTB4R | Q15722 | 1/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.48 |
| ▸ | NPC1 | O15118 | 1/20 | 0.48 |
| ▸ | MAPT | P10636 | 1/20 | 0.48 |
| ▸ | RAB9A | P51151 | 1/20 | 0.48 |
| ▸ | AKT1 | P31749 | 1/20 | 0.47 |
| ▸ | PPARG | P37231 | 1/20 | 0.46 |
| ▸ | TBXAS1 | P24557 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9796771 | 0.94 | TDP1 (0.68) | TDP1LMNATSHRALDH1A1AKT1 | |
| SCHEMBL14926467 | 0.86 | TDP1 (0.51) | TDP1LMNATSHRALDH1A1NPC1 | |
| SCHEMBL28595501 | 0.86 | TSHR (0.66) | TDP1LMNATSHRLTB4RALDH1A1 | |
| Methyl Benzoate SCHEMBL28780286 | 0.85 | TSHR (0.70) | TDP1LMNATSHRALDH1A1NPC1 | |
| SCHEMBL1172574 | 0.85 | TDP1 (0.65) | TDP1LMNATSHRALDH1A1NPC1 | |
| Alkyl (C12-15) Benzoate SCHEMBL27581023 | 0.85 | TDP1 (0.65) | TDP1LMNATSHRALDH1A1NPC1 | |
| SCHEMBL17466182 | 0.85 | TDP1 (0.96) | TDP1LMNATSHRALDH1A1NPC1 | |
| SCHEMBL11896606 | 0.85 | TDP1 (0.96) | TDP1LMNATSHRALDH1A1NPC1 | |
| SCHEMBL225815 | 0.85 | TDP1 (0.96) | TDP1LMNATSHRALDH1A1NPC1 | |
| SCHEMBL2069111 | 0.85 | TDP1 (0.96) | TDP1LMNATSHRALDH1A1NPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2012165550-A1 | CINNAMIC ACID DERIVATIVE, POLYMER THEREOF, AND LIQUID CRYSTAL ALIGNMENT LAYER COMPRISING CURED ARTICLE THEREOF | DIC株式会社 (JP) | 2012-12-06 | — | — | WO | disclosed |
| EP-0455448-B1 | Treatment of pancreatic disease with 15-keto-prostaglandin E compounds | R TECH UENO LTD (JP) | 1998-12-09 | — | — | EP | disclosed |
| EP-0503887-B1 | Promotion of wound-healing with 15-keto-prostaglandin compounds | R TECH UENO LTD (JP) | 1996-08-28 | — | — | EP | disclosed |
| EP-0435443-B1 | Use of 15-keto-prostaglandin compound for improvement of encephalic function | R TECH UENO LTD (JP) | 1996-08-28 | — | — | EP | disclosed |
| EP-0467564-B1 | Treatment of inflammatory diseases with 15-keto-prostaglandin compounds | R TECH UENO LTD (JP) | 1996-04-24 | — | — | EP | disclosed |
| US-5426115-A | Increasing blood stream rate in brain tissue | KABUSHIKIKAISHA UENO SEIYAKU OYO KENKYUJO (JP) | 1995-06-20 | — | — | US | disclosed |
| US-5346921-A | Treatment of inflammation with 15-keto-prostaglandin compounds | R-TECH UENO, LTD. (JP) | 1994-09-13 | — | — | US | disclosed |
| US-5290811-A | Administering as antiischemic or antiedema agent; brain disorders, cognition activators | KABUSHIKI KAISHA UENO SEIYAKU OYO KENKYUJO (JP) | 1994-03-01 | — | — | US | disclosed |
| US-5252605-A | Promotion of wound-healing with 15-keto-prostaglandin compounds | R-TECH UENO LTD. (JP) | 1993-10-12 | — | — | US | disclosed |
| US-5164415-A | Amylase inhibitor | K.K. UENO SEIYAKU OYO KENKYUJO (JP) | 1992-11-17 | — | — | US | disclosed |
| EP-0503887-A2 | Promotion of wound-healing with 15-keto-prostaglandin compounds | R-TECH UENO LTD. (JP) | 1992-09-16 | — | — | EP | disclosed |
| US-5117042-A | 15-KETO-PROSTAGLANDIN COMPOUND FOR IMPROVEMENT OF ENCEPHALIC FUNCTION | K.K. UENO SEIYAKU OYO KENKYUJO (JP) | 1992-05-26 | — | — | US | disclosed |
| EP-0467564-A2 | Treatment of inflammatory diseases with 15-keto-prostaglandin compounds | R-TECH UENO LTD. (JP) | 1992-01-22 | — | — | EP | disclosed |
| EP-0455448-A2 | Treatment of pancreatic disease with 15-keto-prostaglandin compounds | Kabushiki Kaisha Ueno Seiyaku Oyo Kenkyujo (JP) | 1991-11-06 | — | — | EP | disclosed |
| EP-0435443-A2 | Use of 15-keto-prostaglandin compound for improvement of encephalic function | R-TECH UENO LTD. (JP) | 1991-07-03 | — | — | EP | disclosed |